These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36030796)

  • 1. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.
    Perico N; Cortinovis M; Suter F; Remuzzi G
    Lancet Infect Dis; 2023 Jan; 23(1):e22-e33. PubMed ID: 36030796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
    Mariniello DF; Allocca V; D'Agnano V; Villaro R; Lanata L; Bagnasco M; Aronne L; Bianco A; Perrotta F
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
    Capuano A; Scavone C; Racagni G; Scaglione F;
    Pharmacol Res; 2020 Jul; 157():104849. PubMed ID: 32360482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents.
    Alexander PE; Armstrong R; Fareed G; Lotus J; Oskoui R; Prodromos C; Risch HA; Tenenbaum HC; Wax CM; Dara P; McCullough PA; Gill KK
    Med Hypotheses; 2021 Aug; 153():110622. PubMed ID: 34130113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19.
    Kushner P; McCarberg BH; Grange L; Kolosov A; Haveric AL; Zucal V; Petruschke R; Bissonnette S
    NPJ Prim Care Respir Med; 2022 Sep; 32(1):35. PubMed ID: 36127354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of SARS-CoV-2 Infection and COVID-19 Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis.
    Prada L; D Santos C; Baião RA; Costa J; Ferreira JJ; Caldeira D
    J Clin Pharmacol; 2021 Dec; 61(12):1521-1533. PubMed ID: 34352112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
    Metyas S; Chen C; Aung T; Ballester A; Cheav S
    Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
    Shakeeb N; Varkey P; Hynse A; Mandlecha A
    Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
    Moore N; Bosco-Levy P; Thurin N; Blin P; Droz-Perroteau C
    Drug Saf; 2021 Sep; 44(9):929-938. PubMed ID: 34339037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.
    Sisakht M; Solhjoo A; Mahmoodzadeh A; Fathalipour M; Kabiri M; Sakhteman A
    Comput Biol Med; 2021 Sep; 136():104686. PubMed ID: 34340125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
    Kelleni MT
    Inflammopharmacology; 2022 Feb; 30(1):343-348. PubMed ID: 34822026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
    Grieb P; Rejdak K
    Folia Neuropathol; 2021; 59(2):113-120. PubMed ID: 34284539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs for early management of acute respiratory infections.
    Bassetti M; Andreoni M; Santus P; Scaglione F
    Curr Opin Infect Dis; 2024 Aug; 37(4):304-311. PubMed ID: 38779903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
    Carubbi F; Alunno A; Leone S; Di Gregorio N; Mancini B; Viscido A; Del Pinto R; Cicogna S; Grassi D; Ferri C
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.
    Yousefifard M; Zali A; Zarghi A; Madani Neishaboori A; Hosseini M; Safari S
    Int J Clin Pract; 2020 Sep; 74(9):e13557. PubMed ID: 32460369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.